跳至主要内容
临床试验/NCT01004107
NCT01004107已完成不适用

Phase 4, Evaluation of Radiesse® Dermal Filler for Hand Rejuvenation

Merz North America, Inc.4 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2008年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
101
试验地点
4
主要终点
≥ 1-point Change on Busso Hand Volume Severity Scale (BHVSS), by Hand

研究概览

简要总结

The purpose of this study is to assess the safety and effectiveness of Radiesse® Injectable Dermal Filler for hand treatment.

详细描述

This is a prospective, randomized, masked, controlled study to investigate the effectiveness of Radiesse® Dermal Filler for hand treatment.

This is a prospective, randomized, masked, controlled study to investigate the effectiveness of Radiesse® Dermal Filler for hand treatment, comprised of a 3-month main study followed by an open-label extension (OLEX) study through 12 months. At 3 months, untreated controls received Radiesse Dermal Filler for hand treatment and were followed for the remainder of the study. All study subjects were eligible for retreatment 6 months after initial treatment, and all subjects were followed through 12 months from study enrollment in the OLEX.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Radiesse Injectable Dermal Filler

Experimental

Device: Radiesse Injectable Dermal Filler

干预措施: Radiesse Injectable Dermal Filler (Device)

Delayed Treatment

Active Comparator

Cross over to treatment with Radiesse Injectable Dermal Filler at 3 Months

干预措施: Radiesse Injectable Dermal Filler (Device)

结局指标

主要结局

≥ 1-point Change on Busso Hand Volume Severity Scale (BHVSS), by Hand

时间窗: 3 months from baseline

To evaluate the efficacy of Radiesse for hand treatment as measured by a ≥ 1-point change on the 5-point Busso Hand Volume Severity Scale (BHVSS) between baseline and 3 months, by hand, among treated subjects and untreated controls. A measure of successful or improved treatment effect is demonstrated by a decrease in BHVSS score. Busso Hand Volume Severity Scale (BHVSS) rating definitions are as follows: 4 = All 3 central tendons are fully exposed when hand is at rest; 3 = All 3 central tendons are partially exposed with 1 to 2 tendons fully exposed when hand is at rest; 2 = All 3 central tendons are partially exposed when hand is at rest; 1 = One or 2 central tendons are slightly exposed when hand is at rest; and 0 = No tendons exposed when hand is at rest.

Mean Change on Busso Hand Volume Severity Scale (BHVSS), by Hand

时间窗: 3 months from baseline

To evaluate the efficacy of Radiesse for hand treatment as measured by mean change on the 5-point Busso Hand Volume Severity Scale (BHVSS) between baseline and 3 months, by hand, among treated subjects and untreated controls. Ratings were completed by three, blinded evaluators. A measure of successful or improved treatment effect is demonstrated by a decrease in BHVSS score. Busso Hand Volume Severity Scale (BHVSS) rating definitions are as follows: 4 = All 3 central tendons are fully exposed when hand is at rest; 3 = All 3 central tendons are partially exposed with 1 to 2 tendons fully exposed when hand is at rest; 2 = All 3 central tendons are partially exposed when hand is at rest; 1 = One or 2 central tendons are slightly exposed when hand is at rest; and 0 = No tendons exposed when hand is at rest.

≥ 1-point Change on Busso Hand Volume Severity Scale (BHVSS), by Subject

时间窗: 3 months from baseline

To evaluate the efficacy of Radiesse for hand treatment as measured by a ≥ 1-point change on the 5-point Busso Hand Volume Severity Scale (BHVSS) between baseline and 3 months, by subject, among treated subjects and untreated controls. A measure of successful or improved treatment effect is demonstrated by a decrease in BHVSS score. Busso Hand Volume Severity Scale (BHVSS) rating definitions are as follows: 4 = All 3 central tendons are fully exposed when hand is at rest; 3 = All 3 central tendons are partially exposed with 1 to 2 tendons fully exposed when hand is at rest; 2 = All 3 central tendons are partially exposed when hand is at rest; 1 = One or 2 central tendons are slightly exposed when hand is at rest; and 0 = No tendons exposed when hand is at rest.

次要结局

  • Mean Change on Busso Hand Volume Severity Scale (BHVSS), by Hand(3, 6, 9, and 12 months from baseline)
  • Global Aesthetic Improvement Scale (GAIS) Ratings Among the Original Treatment Group and Untreated Controls Only(3 months from baseline)
  • Global Aesthetic Improvement Scale (GAIS) Ratings of at Least "Improved" Among the Original Treatment Group Only(3 months from baseline)
  • Difficulty Performing Activities During Prior Week, Both Hands(Baseline and 3, 6, 9, and 12 months post-treatment)
  • Global Aesthetic Improvement Scale (GAIS) Ratings, by Hand(3, 6, 9, and 12 months from baseline)
  • Patient Satisfaction Evaluation: Likelihood to Return for Future Radiesse Treatments(3, 6, 9, and 12 months from baseline)
  • Normal Work During Prior Week Evaluation(Baseline and 3, 6, 9, and 12 months post-treatment)
  • ≥ 1-point Change on Busso Hand Volume Severity Scale (BHVSS), by Subject(3, 6, 9, and 12 months from baseline)
  • Global Aesthetic Improvement Scale (GAIS) Ratings of at Least "Improved" Over Study(3, 6, 9, and 12 months from baseline)
  • Patient Satisfaction Evaluation(3, 6, 9, and 12 months from baseline)
  • Mean Hand Function Rating During Prior Week(Baseline and 3, 6, 9, and 12 months post-treatment)
  • ≥ 1-point Change on Busso Hand Volume Severity Scale (BHVSS), by Hand(3, 6, 9, and 12 months from baseline)
  • Physician Satisfaction Evaluation(3, 6, 9, and 12 months from baseline)
  • Difficulty Performing Activities During Prior Week(Baseline and 3, 6, 9, and 12 months post-treatment)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验